2023
DOI: 10.3390/life13020354
|View full text |Cite
|
Sign up to set email alerts
|

Robotic Bronchoscopy: Review of Three Systems

Abstract: Robotic bronchoscopy (RB) has been shown to improve access to smaller and more peripheral lung lesions, while simultaneously staging the mediastinum. Pre-clinical studies demonstrated extremely high diagnostic yields, but real-world RB yields have yet to fully matched up in prospective studies. Despite this, RB technology has rapidly evolved and has great potential for lung-cancer diagnosis and even treatment. In this article, we review the historical and present challenges with RB in order to compare three RB… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
13
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 12 publications
(13 citation statements)
references
References 73 publications
(90 reference statements)
0
13
0
Order By: Relevance
“…Surprisingly, the diagnostic yield was not significantly different for guided bronchoscopy procedures performed before and after 2012 [ 39 ]. Robotic bronchoscopy was approved by the FDA in 2018 and has received significant attention [ 40 ]. The combined use of robotic bronchoscopy and other technologies, such as cone-beam computed tomography (CT), prevents CT-to-body divergence to optimize biopsy tool-in-lesion [ 41 ].…”
Section: Reviewmentioning
confidence: 99%
“…Surprisingly, the diagnostic yield was not significantly different for guided bronchoscopy procedures performed before and after 2012 [ 39 ]. Robotic bronchoscopy was approved by the FDA in 2018 and has received significant attention [ 40 ]. The combined use of robotic bronchoscopy and other technologies, such as cone-beam computed tomography (CT), prevents CT-to-body divergence to optimize biopsy tool-in-lesion [ 41 ].…”
Section: Reviewmentioning
confidence: 99%
“…Until recently, two robotic platforms were approved by the FDA, namely, the Monarch (in 2018) and the Ion Endoluminal (in 2019) System by Auris Health Inc. (Redwood City, CA, USA) and Intuitive Surgical (Sunnyvale, CA, USA), respectively [ 24 ]. In 2023, FDA clearance was also granted to the Galaxy System by Noah Medical (San Carlos, CA, USA) [ 30 , 31 ]. Table 1 shows a comparison of the technical characteristics of these platforms.…”
Section: Robotic Bronchoscopy Platformsmentioning
confidence: 99%
“… Pictures of the ( A ) Monarch platform, ( B ) Ion Endoluminal platform, and ( C ) Galaxy platform [ 31 ]. …”
Section: Figurementioning
confidence: 99%
“…There is a 2.1 mm working channel, and the catheter has an incorporated video transmission system allowing for an "always on" frontal white light view during the biopsy. Monarch is the EMN-based robotic bronchoscopy (EMN-RAB) prototype [28][29][30] (Figure 2). The Ion Endoluminal System (Intuitive Surgical, Sunnyvale, CA) utilizes a novel shape sensing technique (ssRAB) that allows for real-time location of a 3.5mm bronchoscopic catheter based on its deformation while navigating the airways.…”
Section: Robotically Assisted Bronchoscopy (Rab): Available Technologiesmentioning
confidence: 99%